|
|
||||||||
|
FIGURE 5. Effect of 188Re-(Arg11)CCMSH treatment on growth rate of TXM13 human melanoma tumors. Measurable TXM13 tumors were obtained on day 0 and treated with 188Re-(Arg11)CCMSH on day 4. Tumor measurements were performed twice a week starting 4 d after administration of 22.2 MBq (
), 2 x 14.8 MBq (), and 37.0 MBq (
) of 188Re-(Arg11)CCMSH or saline placebo (
). Second 14.8 MBq dose was given on day 18.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |